OncoTherapy Science (4564) · PolicyFirst stated

Fair recruitment and promotion of specialized personnel and training aligned with R&D stages

First written in FY2023. . Latest entry: FY2023.

1entries

1years

0from disclosures

How it moved

Same theme, other companies

Strengthening R&D staffing and development capabilitiesA theme 51 companies write about · 0 as a headwind · 52 as a tailwind

The whole theme swung hardest in 2026: 3 of 34 companies on the "Worse" side.

0 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Showing 14 of the 51 companies compared. The sentences above are computed from all 51.

Full recordFilings, disclosures and news, newest first

FY2023First statedAnnual report
「As a research and development-oriented company, the group requires highly specialized personnel. It has long recruited and promoted personnel needed to operate its businesses without regard to nationality, gender or other such distinctions. It also operates training plans that enable employees to acquire the necessary skills smoothly, including by providing training tailored to each stage of research and development.」
As part of its sustainability strategy, the company has for the first time explicitly described recruitment and promotion without regard to nationality, gender or other factors, together with training aligned with the stages of research and development.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

No upcoming earnings preview for OncoTherapy Science yet.

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.